Cargando…
Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru
BACKGROUND: Nearly half of the world’s population is at risk for dengue, yet no licensed vaccine or anti-viral drug is currently available. Dengue is caused by any of four dengue virus serotypes (DENV-1 through DENV-4), and infection by a DENV serotype is assumed to provide life-long protection agai...
Autores principales: | Forshey, Brett M., Reiner, Robert C., Olkowski, Sandra, Morrison, Amy C., Espinoza, Angelica, Long, Kanya C., Vilcarromero, Stalin, Casanova, Wilma, Wearing, Helen J., Halsey, Eric S., Kochel, Tadeusz J., Scott, Thomas W., Stoddard, Steven T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746126/ https://www.ncbi.nlm.nih.gov/pubmed/26848841 http://dx.doi.org/10.1371/journal.pntd.0004398 |
Ejemplares similares
-
Long-Term and Seasonal Dynamics of Dengue in Iquitos, Peru
por: Stoddard, Steven T., et al.
Publicado: (2014) -
Dengue Virus Serotype 4, Northeastern Peru, 2008
por: Forshey, Brett M., et al.
Publicado: (2009) -
Epidemiology of influenza‐like illness in the Amazon Basin of Peru, 2008–2009
por: Forshey, Brett M., et al.
Publicado: (2010) -
Epidemiology of Dengue Virus in Iquitos, Peru 1999 to 2005: Interepidemic and Epidemic Patterns of Transmission
por: Morrison, Amy C., et al.
Publicado: (2010) -
Venezuelan Equine Encephalitis and 2 Human Deaths, Peru
por: Vilcarromero, Stalin, et al.
Publicado: (2010)